Literature DB >> 34292963

In vivo recellularization of xenogeneic vascular grafts decellularized with high hydrostatic pressure method in a porcine carotid arterial interpose model.

Shunji Kurokawa1, Yoshihide Hashimoto2, Seiichi Funamoto2,3, Kozue Murata1,4, Akitatsu Yamashita2, Kazuhiro Yamazaki1, Tadashi Ikeda1, Kenji Minatoya1, Akio Kishida2, Hidetoshi Masumoto1.   

Abstract

Autologous vascular grafts are widely used in revascularization surgeries for small caliber targets. However, the availability of autologous conduits might be limited due to prior surgeries or the quality of vessels. Xenogeneic decellularized vascular grafts from animals can potentially be a substitute of autologous vascular grafts. Decellularization with high hydrostatic pressure (HHP) is reported to highly preserve extracellular matrix (ECM), creating feasible conditions for recellularization and vascular remodeling after implantation. In the present study, we conducted xenogeneic implantation of HHP-decellularized bovine vascular grafts from dorsalis pedis arteries to porcine carotid arteries and posteriorly evaluated graft patency, ECM preservation and recellularization. Avoiding damage of the luminal surface of the grafts from drying significantly during the surgical procedure increased the graft patency at 4 weeks after implantation (P = 0.0079). After the technical improvement, all grafts (N = 5) were patent with mild stenosis due to intimal hyperplasia at 4 weeks after implantation. Neither aneurysmal change nor massive thrombosis was observed, even without administration of anticoagulants nor anti-platelet agents. Elastica van Gieson and Sirius-red stainings revealed fair preservation of ECM proteins including elastin and collagen after implantation. The luminal surface of the grafts were thoroughly covered with von Willebrand factor-positive endothelium. Scanning electron microscopy of the luminal surface of implanted grafts exhibited a cobblestone-like endothelial cell layer which is similar to native vascular endothelium. Recellularization of the tunica media with alpha-smooth muscle actin-positive smooth muscle cells was partly observed. Thus, we confirmed that HHP-decellularized grafts are feasible for xenogeneic implantation accompanied by recellularization by recipient cells.

Entities:  

Year:  2021        PMID: 34292963     DOI: 10.1371/journal.pone.0254160

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


  28 in total

Review 1.  Role of prosthetic conduits in coronary artery bypass grafting.

Authors:  Mital Desai; Alexander M Seifalian; George Hamilton
Journal:  Eur J Cardiothorac Surg       Date:  2011-01-08       Impact factor: 4.191

2.  Mid- to long-term outcomes of cardiovascular tissue replacements utilizing homografts harvested and stored at Japanese institutional tissue banks.

Authors:  Soichiro Kitamura; Toshikatsu Yagihara; Junjiro Kobayashi; Hiroyuki Nakajima; Koichi Toda; Tomoyuki Fujita; Hajime Ichikawa; Hitoshi Ogino; Takeshi Nakatani; Shigeki Taniguchi
Journal:  Surg Today       Date:  2011-03-23       Impact factor: 2.549

3.  Immunological and histological evaluation of decellularized allograft in a pig model: comparison with cryopreserved allograft.

Authors:  Satoshi Numata; Toshiya Fujisato; Kazuo Niwaya; Hatsue Ishibashi-Ueda; Takeshi Nakatani; Soichiro Kitamura
Journal:  J Heart Valve Dis       Date:  2004-11

4.  Optimal conduit choice in the absence of single-segment great saphenous vein for below-knee popliteal bypass.

Authors:  James T McPhee; Neal R Barshes; C Keith Ozaki; Louis L Nguyen; Michael Belkin
Journal:  J Vasc Surg       Date:  2012-02-24       Impact factor: 4.268

5.  In vivo performance of freeze-dried decellularized pulmonary heart valve allo- and xenografts orthotopically implanted into juvenile sheep.

Authors:  Tobias Goecke; Karolina Theodoridis; Igor Tudorache; Anatol Ciubotaru; Serghei Cebotari; Robert Ramm; Klaus Höffler; Samir Sarikouch; Andrés Vásquez Rivera; Axel Haverich; Willem F Wolkers; Andres Hilfiker
Journal:  Acta Biomater       Date:  2017-12-02       Impact factor: 8.947

6.  Decellularization combined with enzymatic removal of N-linked glycans and residual DNA reduces inflammatory response and improves performance of porcine xenogeneic pulmonary heart valves in an ovine in vivo model.

Authors:  Robert Ramm; Tobias Goecke; Karolina Theodoridis; Klaus Hoeffler; Samir Sarikouch; Katja Findeisen; Anatol Ciubotaru; Serghei Cebotari; Igor Tudorache; Axel Haverich; Andres Hilfiker
Journal:  Xenotransplantation       Date:  2019-11-26       Impact factor: 3.907

7.  Porcine radial artery decellularization by high hydrostatic pressure.

Authors:  Jun Negishi; Seiichi Funamoto; Tsuyoshi Kimura; Kwangoo Nam; Tetsuya Higami; Akio Kishida
Journal:  J Tissue Eng Regen Med       Date:  2012-12-12       Impact factor: 3.963

8.  Histopathologic changes of acellularized xenogenic carotid vascular grafts implanted in a pig-to-goat model.

Authors:  W S Kim; J W Seo; J R Rho; W G Kim
Journal:  Int J Artif Organs       Date:  2007-01       Impact factor: 1.595

Review 9.  Exploring the full spectrum of macrophage activation.

Authors:  David M Mosser; Justin P Edwards
Journal:  Nat Rev Immunol       Date:  2008-12       Impact factor: 53.106

10.  The Tissue-Engineered Vascular Graft-Past, Present, and Future.

Authors:  Samand Pashneh-Tala; Sheila MacNeil; Frederik Claeyssens
Journal:  Tissue Eng Part B Rev       Date:  2015-10-08       Impact factor: 6.389

View more
  2 in total

Review 1.  Extracellular Matrix-Based Biomaterials for Cardiovascular Tissue Engineering.

Authors:  Astha Khanna; Maedeh Zamani; Ngan F Huang
Journal:  J Cardiovasc Dev Dis       Date:  2021-10-22

2.  Extraction and Biological Evaluation of Matrix-Bound Nanovesicles (MBVs) from High-Hydrostatic Pressure-Decellularized Tissues.

Authors:  Mako Kobayashi; Naoki Ishida; Yoshihide Hashimoto; Jun Negishi; Hideki Saga; Yoshihiro Sasaki; Kazunari Akiyoshi; Tsuyoshi Kimura; Akio Kishida
Journal:  Int J Mol Sci       Date:  2022-08-09       Impact factor: 6.208

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.